Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Runhui Zheng"'
Autor:
Jing Zhang, Jinpeng Cao, Runhui Zheng, Mengqiu Yu, Zhengfang Lin, Caixia Wang, James McCluskey, Ji Yang, Zhenjun Chen, Alexandra J. Corbett, Pengxing Cao, Wenjian Mo, Zhongfang Wang
Publikováno v:
iScience, Vol 25, Iss 11, Pp 105340- (2022)
Summary: The dynamic interaction between the CMV virus and host immune response remains obscure, thus hindering the diagnosis and therapeutic management of patients with HSCT. The current diagnosis of CMV viremia depends on viral load estimation. Med
Externí odkaz:
https://doaj.org/article/a9130cb247cc4c7996b94448e9d11b43
Autor:
Runhui Zheng, Jing Zhou, Bin Song, Xia Zheng, Ming Zhong, Li Jiang, Chun Pan, Wei Zhang, Jiaan Xia, Nanshan Chen, Wenjuan Wu, Dingyu Zhang, Yin Xi, Zhimin Lin, Ying Pan, Xiaoqing Liu, Shiyue Li, Yuanda Xu, Yimin Li, Huo Tan, Nanshan Zhong, Xiaodan Luo, Ling Sang
Publikováno v:
Experimental Hematology & Oncology, Vol 10, Iss 1, Pp 1-11 (2021)
Abstract Background Coronavirus disease 2019 (COVID-19) is associated with coagulation abnormalities which are indicators of higher mortality especially in severe cases. Methods We studied patients with proven COVID-19 disease in the intensive care u
Externí odkaz:
https://doaj.org/article/55891629133d4136af3e496783d4a742
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 8, Pp 986-987 (2022)
Externí odkaz:
https://doaj.org/article/c61c50d942a0439d8487624821154bf3
Autor:
Ling Xu, Lian Liu, Danlin Yao, Xiangbo Zeng, Yikai Zhang, Jing Lai, Jun Zhong, Xianfeng Zha, Runhui Zheng, Yuhong Lu, Minming Li, Zhenyi Jin, Sudheendra Hebbar Subramanyam, Shaohua Chen, Xin Huang, Yangqiu Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Despite the great success of immune-checkpoint inhibitor (ICI) treatment for multiple cancers, evidence for the clinical use of ICIs in acute myeloid leukemia (AML) remains inadequate. Further exploration of the causes of immune evasion in the bone m
Externí odkaz:
https://doaj.org/article/0530309469c6485484285932f806bf03
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Double-expressor diffuse large B-cell lymphoma (DLBCL) with 17p deletion is an aggressive and refractory disease. Immune checkpoint blockade and epigenetic drugs have been widely used, but the efficacy of different combined applications varied. We re
Externí odkaz:
https://doaj.org/article/0190a0af14a5460488c58aae0aecdfbb
Autor:
Tingting Cui, Mingzhu Huang, Yuan Wang, Zhengfang Lin, Xiaoling Su, Weidong Li, Qi Luo, Kaiyi Li, Chunyan Wang, Runhui Zheng, Zhongfang Wang
Background Why Epstein–Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH) undergoes remission shortly after treatment and relapses rapidly and whether EBV infection in natural killer (NK)/T cells contributes to the deterioration of EBV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7f5c3ef6c6e3739c085cddb14351183
https://doi.org/10.21203/rs.3.rs-1970948/v1
https://doi.org/10.21203/rs.3.rs-1970948/v1
Autor:
Qingqing Cai, Yi Xia, Hui Zhou, Wenyu Li, Zhiming Li, Xu Ye, Yudan Wu, Huo Tan, Runhui Zheng, Bingyi Wu, Hui Yang, Yuhong Lu, Yang Liang, Ning Su, Qihua Zou, Panpan Liu
Publikováno v:
Blood. 140:9450-9451
Autor:
Jing Zhang, Jinpeng Cao, Runhui Zheng, Mengqiu Yu, Zhengfang Lin, Caixia Wang, James McCluskey, Ji Yang, Zhenjun Chen, Alexandra J. Corbett, Pengxing Cao, Wenjian Mo, Zhongfang Wang
Publikováno v:
SSRN Electronic Journal.
Autor:
Xiangbo Zeng, Zhenyi Jin, Ling Xu, Xin Huang, Juan Zhong, Yuhong Lu, Shaohua Chen, Lian Liu, Danlin Yao, Jing Lai, Xianfeng Zha, Runhui Zheng
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2020 (2020)
BioMed Research International, Vol 2020 (2020)
The antitumor activity of NK cells in patients with chronic myeloid leukemia (CML) is inhibited by the leukemia microenvironment. Recent studies have identified that the expression of TIGIT, CD57, and KLRG1 is related to the function, maturation, and
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2020 (2020)
Case Reports in Hematology, Vol 2020 (2020)
Double-expressor diffuse large B-cell lymphoma (DLBCL) with17pdeletion is an aggressive and refractory disease. Immune checkpoint blockade and epigenetic drugs have been widely used, but the efficacy of different combined applications varied. We repo